Dr. Richard Ramas Gillespie Jr., MD

Dr. Gillespie practices at Queen City Ear Nose And Throat in Charlotte, North Carolina.

Dr. Gillespie's NPI, 1083644678, was assigned on July 3, 2006. Dr. Gillespie graduated from Duke University School Of Medicine in 1994. Dr. Gillespie holds North Carolina license 200100689.

Dr. Gillespie's primary practice is Queen City Ear Nose and Throat, at 8924 Blakeney Professional Dr, Charlotte, NC 28277-6660. The practice phone is (704) 703-1080.

Dr. Gillespie's primary practice is Queen City Ear Nose And Throat in Charlotte, North Carolina. Dr. Gillespie is also affiliated with Atrium Health Carolinas Medical Center. The medical group on file is Queen City Ear Nose and Throat. Dmand AI also links Dr. Gillespie to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gillespie practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Gillespie's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Gillespie is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Gillespie's licenses on file in 4 states: North Carolina, South Carolina, Georgia and Texas.

Dmand AI lists acute sinusitis, chronic ear infection, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and swimmer's ear among the conditions Dr. Gillespie treats.

CMS data shows 503 Medicare services from Dr. Gillespie across 16 procedure codes in 2024, for 209 Medicare patients. Medicare paid $30,279 for them. Every service was in an office.

CMS counts 209 Medicare patients who saw Dr. Gillespie in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gillespie's median patient age at 57, with 50% women.

In 2024, Dr. Gillespie wrote 322 Medicare Part D claims for 130 patients. 96% of them were for generic drugs. CMS names the drug for 251 of them, across 11 drugs with 11 or more claims each, at $6,469 in total drug cost. In 2023, CMS named 187 claims across 7 drugs.

Dr. Gillespie accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 117 general payments to Dr. Gillespie from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Inspire Medical Systems, Inc. paid the most, $1,924.

Dmand AI lists 2 awards for Dr. Gillespie, most recently CMS Stage 1 EHR in 2013.

Dr. Gillespie graduated from Duke University School Of Medicine in 1994. Dr. Gillespie is a member of NHS.

Dr. Gillespie is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.